P. Roy Vagelos, Chairman of the Board at REGENERON PHARMACEUTICALS INC (REGN), sold 313,421 shares at $302.86 ($94.9M) on 2013-09-19, disclosed to the SEC on 2013-09-20.
Scheduled sale ($94.9M) by Chairman of the Board under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 921 | $0 | 0.0% |
| 2 | $304.38 | 13,346 | $4.1M | 4.3% |
| 3 | $304.38 | 153,798 | $46.8M | 49.3% |
| 4 | $300.34 | 61,159 | $18.4M | 19.4% |
| 5 | $301.42 | 21,179 | $6.4M | 6.7% |
| 6 | $302.86 | 10,742 |
| $3.3M |
| 3.4% |
| 7 | $303.49 | 6,780 | $2.1M | 2.2% |
| 8 | $304.80 | 11,286 | $3.4M | 3.6% |
| 9 | $305.28 | 13,126 | $4.0M | 4.2% |
| 10 | $306.46 | 5,084 | $1.6M | 1.6% |
| 11 | $308.40 | 4,500 | $1.4M | 1.5% |
| 12 | $309.84 | 2,600 | $806K | 0.8% |
| 13 | $310.18 | 8,900 | $2.8M | 2.9% |
| Total | $302.78 avg | 313,421 | $94.9M | 100% |
| Filing → |
| REGN | SELL | 2020-08-13 | $39.7M | — | Filing → |
| REGN | SELL | 2020-05-22 | $168.0M | — | Filing → |
| REGN | SELL | 2020-05-22 | $847K | — | Filing → |